Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Haematologica|May 6, 2021
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphomaJoan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, et al.
Blood|August 27, 2005
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profilingKai Fu, Dennis D Weisenburger, Timothy C Greiner, et al.
Cancer Cell|July 31, 2018
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/LymphomaMasao Nakagawa, Arthur L Shaffer, Michele Ceribelli, et al.
Blood|September 28, 2018
Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimensAnja Mottok, George Wright, Andreas Rosenwald, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Nature Medicine|July 21, 2015
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphomaWyndham H Wilson, Ryan M Young, Roland Schmitz, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Blood|December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaJaveed Iqbal, Yulei Shen, Xin Huang, et al.
Pageof 8